Frontiers in oncology.

Introduction. Indeed, publications concerning radiomic technique for oncology keep increasing over the past decade. In their valuable article, Ding et al. conducted a bibliometric analysis on the field of radiomics in oncology, with the aim of informing beginners and encouraging more researchers to participate in practicing …Figure 1 Hierarchical divisive clustering of brain tumor patients, based on the collected features. The dendrogram reporting the clusters identified through divisive hierarchical clustering is reported. Gower distance is reported on the y axis and each single unit analyzed (i.e. patients) on the x axis. Scope. Breast Cancer is a specialty section of Oncology dedicated to advancing scientific and clinical knowledge of breast cancers. This section seeks to publish articles addressing novel findings, controversies, and innovative hypotheses in the areas of prevention, diagnosis, and treatment of early breast lesions and breast malignancies. Frontiers in Oncology publishes peer-reviewed articles across the entire field of cancer research, from basic to clinical. It is a multidisciplinary journal with a high impact factor and a global reach, …Scope. This section of Frontiers in Oncology aims to create an open access, rapid, transparent and interactive exchange of findings for the neuro-oncology and neurosurgical oncology communities. We welcome contributions from the basic and translational neurosciences, in addition to research derived from clinical studies and …

The objective of the Skin Cancer section is to expand our understanding of molecular and cellular mechanisms involved in skin cancer progression. Moreover, the section is dedicated to the publication of high-quality clinical, translational research as well as bioinformatics studies in a timely manner. We are especially interested in receiving ...Optimizing the first-line treatment for metastatic colorectal cancer. The prognosis of metastatic CRC (mCRC) patients has significantly improved in the past 20 years thanks to the introduction of novel therapeutic approaches, including surgery of liver, lung and peritoneal metastases, and of more effective anticancer drugs and combinatory ...

Jul 4, 2022 · 1 Cancer Research Center for Health Equity, Division of Medical Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, United States; 2 Norris Comprehensive Cancer Center, University of Southern California, Keck School of Medicine, Los Angeles, CA, United States Introduction. Indeed, publications concerning radiomic technique for oncology keep increasing over the past decade. In their valuable article, Ding et al. conducted a bibliometric analysis on the field of radiomics in oncology, with the aim of informing beginners and encouraging more researchers to participate in practicing …

Frontiers works with research institutions, libraries, consortia, and funders to support authors who want to publish in a Frontiers journal. A central invoicing platform removes the burden from authors and helps contribute to the growing number of research articles that are openly available to all. Organizations can become institutional members ...Gostaríamos de exibir a descriçãoaqui, mas o site que você está não nos permite.2 days ago · Guohui Cao. Hongtao Zhang. Juan Wang. Frontiers in Oncology. doi 10.3389/fonc.2024.1339955. 304 views. Part of a multidisciplinary journal, this section explores the impact of genetic aberrations in carcinogenesis, as well as in the progression and outcomes of cancer. Frontiers in Immuno-Oncology. Print Special Issue Flyer. Special Issue Editors. Special Issue Information. Keywords. Published Papers. A special issue of …

James L. Gulley. Frontiers in Oncology. doi 10.3389/fonc.2024.1376622. 218 views. Driving the fast-moving field of immunosurveillance, tumor escape and cancer immunotherapy by hosting research, discussion and new hypotheses.

See all (158) Learn more about Research Topics. Part of a multidisciplinary journal, this section explores all aspects of hematological malignancies, including acute and chronic leukemia, lymphoma and plasma and hematopoietic stem cell disorders.

Quan Yuan. Yunmei Wang. Frontiers in Oncology. doi 10.3389/fonc.2024.1325362. Part of a multidisciplinary journal, this section explores the development of personalized and tailored approaches to the prevention, diagnosis, and treatment of breast malignancies.Epigenetic and Metabolic Regulators of Breast Carcinogenesis. Iman Mamdouh Talaat. Maha Mohamed Saber-Ayad. Hauke Busch. Noha Mousaad Elemam. 21,657 views. 14 articles. Part of a multidisciplinary journal, this section explores the development of personalized and tailored approaches to the prevention, diagnosis, and treatment of …Yunmei Wang. Frontiers in Oncology. doi 10.3389/fonc.2024.1325362. Part of a multidisciplinary journal, this section explores the development of personalized and tailored approaches to the prevention, diagnosis, and treatment of breast malignancies.Scope. The field of radiation oncology is currently entering a new frontier of more personalized cancer treatment. We are being led into this new frontier by the explosion of information in cancer biology. From the maturation of 3-dimensional (3-D) to 4- dimensional (4-D) photon and proton radiation planning and delivery, and the refinement of ...Here, introducing Frontiers in Oncology: Quarterly Highlights, we feature a collection of carefully selected articles published during the first quarter of 2019 across the different sections. With a record number of papers to choose from, the papers enclosed in this Special Edition highlight some of the recent advances across the different ...The Cancer Imaging and Image-directed Interventions Section is dedicated to the publication of results from clinical and research imaging studies applied to cancer discovery, diagnosis, and treatment. The section will accept studies from the entire field of cancer imaging: results from the routine use of clinical imaging in both radiology and ...harry burke. Uniformed Services University of the Health Sciences. Bethesda, United States. Associate Editor. Cancer Molecular Targets and Therapeutics. Part of a multidisciplinary journal, this section explores targetable intervenients in cancer signaling pathways and their application in drug development and therapeutics.

3 days ago · James L. Gulley. Frontiers in Oncology. doi 10.3389/fonc.2024.1376622. 218 views. Driving the fast-moving field of immunosurveillance, tumor escape and cancer immunotherapy by hosting research, discussion and new hypotheses. 32. Guittet L, Quipourt V, Aparicio T, Carola E, Seitz JF, Paillaud E, et al. Should we screen for colorectal cancer in people aged 75 and over? A systematic review - collaborative work of the French geriatric oncology society (SOFOG) and the French federation of digestive oncology (FFCD). BMC Cancer (2023) 23(1):17. doi: …Introduction. The field of oncology is rapidly changing, with a major shift from broad-acting cytotoxic chemotherapy to drugs targeting specific molecular and immunological mechanisms (1–4).This is reflected by an ongoing increase in number of immuno-oncological agents in development, even during the COVID-19 pandemic …Scope. This section of Frontiers in Oncology aims to create an open access, rapid, transparent and interactive exchange of findings for the neuro-oncology and neurosurgical oncology communities. We welcome contributions from the basic and translational neurosciences, in addition to research derived from clinical studies and …ISSN 2234-943X (Online) | Frontiers in oncology. Skip to main content. Leave this field blank . Log In; Automatic login IP; PUBLISHERS' AREA DISCOVER ISSN SERVICES SEARCH OPEN ACCESS RESOURCES KEEPERS ... Frontiers. CLOCKSS Archive. 2011. 2024. 10/05/2024. 1 to 14. Preserved. Scholars Portal. 02/05/2024. Preserved : …timothy james kinsella. Department of Radiation Oncology, Warren Alpert Medical School, Brown University. Providence, United States. Specialty Chief Editor. Radiation Oncology.

This section provides broad mechanistic and translational insights into all aspects of cancer and its interaction with components of the tumor-microenvironment.The best modem for Frontier DSL is the Actiontec 300 Mbps, a Frontier-compatible modem with rating of four out of five stars on Amazon.com. Other Frontier-compatible modems include...

They should provide the following: 1) Discuss current advances and future directions, 2) Clear presentation of the authors’ perspective, 3) Accurate presentation and citations of other authors’ work, 4) May include original data as well as personal insights and opinions.The Pediatric Oncology section of Frontiers in Oncology aims to provide fair and rapid peer review in order to publish scientific advances for the benefit of all members of the pediatric oncology community, from basic scientists, to clinical researchers, and to caregivers. Pediatric Oncology has experienced great successes in the last 40 years ...Chengli Wang. Liling Lin. Jiayao Wu. Ganglan Fu. Zhongqi Liu. Minghui Cao. Frontiers in Oncology. doi 10.3389/fonc.2024.1345766. This section explores molecular and clinical characteristics of a broad group of malignancies with special interest on the biology and therapeutic strategies for head and neck cancer subtypes.1 Hookipa Pharma Inc., New York, NY, United States; 2 Department of Biomedicine - Haus Petersplatz, Division of Experimental Virology, University of Basel, Basel, Switzerland; Engineered viral vectors represent a promising strategy to trigger antigen-specific antitumor T cell responses. Arenaviruses have been widely studied …Frontiers in Oncology. doi 10.3389/fonc.2024.1387535. 180 views Brief Research Report. Accepted on 29 Apr 2024 Blockade of Tumor Cell-Intrinsic PD-L1 Signaling Enhances AURKA-Targeted Therapy in Triple Negative Breast Cancer. in Cancer Molecular Targets and Therapeutics.SLAS Discovery (2018) 23 (6):574–84. doi: 10.1177/2472555218766842. Keywords: organoids, precision medicine, treatment response, treatment prediction, cancer, patient-derived. Citation: Verduin M, Hoeben A, De Ruysscher D and Vooijs M (2021) Patient-Derived Cancer Organoids as Predictors of Treatment Response.

Giacomo Corrado. Enrico Vizza. Ignacio Zapardiel. Frontiers in Oncology. doi 10.3389/fonc.2024.1393707. Part of a multidisciplinary journal, this section explores the development of a personalized and tailored approach to the prevention and treatment of gynecologic malignancies.

SLAS Discovery (2018) 23 (6):574–84. doi: 10.1177/2472555218766842. Keywords: organoids, precision medicine, treatment response, treatment prediction, cancer, patient-derived. Citation: Verduin M, Hoeben A, De Ruysscher D and Vooijs M (2021) Patient-Derived Cancer Organoids as Predictors of Treatment Response.

Browse the latest research articles published in Frontiers in Oncology, a leading open access journal in the field of cancer. Find original research, reviews, …Getting started. The submitting and corresponding author (s) must register and log in with Frontiers to be able to follow the review process. Ensure that your manuscript fits the scope of the journal/section/Research Topic in which it will be submitted and that you have chosen the correct article type. Submission of the wrong article type or to ...Many modern immunotherapies focus on blood-based cancers, like the leukemias and lymphomas that ONO researcher's study, but solid tumours could also benefit ...The inherent properties of nanobodies make them advantageous for cancer applications ().Their nanoscale dimensions enable deep penetration of tumors, with certain nanobodies able to cross the blood brain barrier (BBB) ().Nanobodies also retain high affinity and specificity for their target antigens, with low off-target accumulation due to …Since then, the development of ICIs represents a paradigm shift in oncology therapy and prompted us to further study the role of ICIs in treatment of patients with BM. The Checkmate 204 trial of dual ICI therapy showed a dramatic intracranial response rate of 57% of BM from melanoma ( 10 ), as did the randomized phase II ABC …6th EMERGING FRONTIERS IN ONCOLOGY 6th EMERGING FRONTIERS IN ONCOLOGY 6th EMERGING FRONTIERS IN ONCOLOGY. MARCH 21, 2024 | 1:00 P.M. - 7:30 P.M. ET . The Broad Institute | 415 Main Street, Cambridge MA, 0214. Register now. Online registration will close on Tuesday, March 19th at 3:00pm ET.francesco giovinazzo. Unit of General and Liver Transplant Surgery, Department of Medical and Surgical Sciences, Agostino Gemelli University Polyclinic (IRCCS) Rome, Italy. Specialty Chief Editor. Surgical Oncology.Frontiers in Oncology is a broad-scope, multidisciplinary journal covering all areas of cancer research to advance our knowledge of cancer epidemiology to improve diagnosis, therapeutics and...Research Topics. This section explores basic science, translational and clinical aspects of Cancer Metabolism, with a particular emphasis on energy metabolism and metabolic reprogramming in cancer cells. Frontiers Media S.A., Switzerland Manuscripts accepted in English LCC subjects Look up the Library of Congress Classification Outline Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens Keywords

A future TCR-T therapy encompassing multiple innovations is illustrated in Figure 15, as an example of the driving force in the E2E Platform applied across multiple modules to support the goal of developing differentiated, best-in-class TCR-T therapies as new and better treatment options for cancer patients.Jul 6, 2018 · The Impact Factor for Frontiers in Oncology is based on 2,358 citations in 2017 to 296 articles published in 2015 and 2016, and for CiteScore is based on 4,138 citations in 2017 to 930 articles published in 2014, 2015 and 2016. A total of 222 journals are listed in the Oncology category in the 2017 JCR edition, of which 37 are Open Access. This Frontiers in Oncology Special Issue marks the 1st edition of a collection of selected articles published in the journal over the course of the previous calendar year, highlighting ongoing research and advances being carried out in the different disciplines of cancer research.In this Research Topic, “ Recent Advances in Boron Neutron Capture Therapy in Radiation Oncology ”, there were four papers published. Hsu et al. discussed developing a tumor control probability (TCP) model from a clinical trial done in Taiwan for recurrent head and neck (H&N) cancer. Their analysis showed the generalized Equivalent Uniform ...Instagram:https://instagram. homeaglow cleaninghigh heeled shoesonline play rummytimer time timer Frontiers in Oncology publishes articles on the most outstanding discoveries across the entire research spectrum of Oncology. The mission of Frontiers in Oncology is to bring … map of daytona beach floridajax flights The Impact Factor for Frontiers in Oncology is based on 2,358 citations in 2017 to 296 articles published in 2015 and 2016, and for CiteScore is based on 4,138 citations in 2017 to 930 articles published in 2014, 2015 and 2016. A total of 222 journals are listed in the Oncology category in the 2017 JCR edition, of which 37 are Open Access.Our goal is to encourage interdisciplinary communication and collaborative research among basic scientists, epidemiologists, clinicians, and public health … translate english to slovak Oncology. Oncology is a specialized field of medicine that focuses on the prevention, diagnosis, and treatment of various types of cancer. Our Research Topics explore key advancements in oncology which have led to significant breakthroughs in cancer care, such as targeted therapies, immunotherapy, and precision medicine.Milan Teraiya. Helene Perreault. Vincent C. Chen. Frontiers in Oncology. doi 10.3389/fonc.2023.1166207. 5,424 views. 2 citations. Explores intracellular and extracellular signaling across all types of cancers.